Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis.
Immunotherapy
; 9(12): 979-993, 2017 09.
Article
in En
| MEDLINE
| ID: mdl-28971751
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
B-Lymphocytes
/
T-Lymphocytes
/
Immunotherapy, Adoptive
/
Antigens, CD20
/
Antigens, CD19
/
Hematologic Neoplasms
Type of study:
Systematic_reviews
Limits:
Animals
/
Humans
Language:
En
Journal:
Immunotherapy
Journal subject:
ALERGIA E IMUNOLOGIA
/
TERAPEUTICA
Year:
2017
Document type:
Article
Country of publication:
Reino Unido